Innate Pharma SA Vs. Cellectis SA Industry Stock Comparison

Sell

13

IPHA
Innate Pharma SA

Last Price:

1.90

Seasonality Move:

18.08%

Sell

43

CLLS
Cellectis SA

Last Price:

1.81

Seasonality Move:

24.63%

Sell

13

Innate Pharma SA (IPHA) is a Sell

Is Innate Pharma SA a Buy, Sell or Hold?

The current Innate Pharma SA [IPHA] share price is $1.83. The Score for IPHA is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
IPHA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

43

Cellectis SA (CLLS) is a Sell

Is Cellectis SA a Buy, Sell or Hold?

The current Cellectis SA [CLLS] share price is $1.81. The Score for CLLS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
CLLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IPHA Stock Price Chart

What is Innate Pharma SA's stock price today?

The Innate Pharma SA share price today is $1.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing buying pressure, which is a positive indicator for future bullish movement.

CLLS Stock Price Chart

What is Cellectis SA's stock price today?

The Cellectis SA share price today is $1.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLLS is experiencing slight selling pressure.

IPHA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.1	Sell
Relative Strength Index (14 RSI):	39.58	Sell
Chaikin Money Flow:	5432	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.88 - 2.18)	Sell
Bollinger Bands (100):	(2 - 2.34)	Sell

CLLS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.08	Sell
Relative Strength Index (14 RSI):	38.78	Sell
Chaikin Money Flow:	-18353	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.85 - 2.07)	Sell
Bollinger Bands (100):	(1.93 - 2.29)	Sell

IPHA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.85	Sell
20-day SMA:	2	Sell
50-day SMA:	2.15	Sell
200-day SMA:	2.38	Sell
8-day EMA:	1.86	Sell
20-day EMA:	1.97	Sell
50-day EMA:	2.09	Sell
200-day EMA:	2.34	Sell

CLLS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.87	Sell
20-day SMA:	1.92	Sell
50-day SMA:	2.13	Sell
200-day SMA:	2.43	Sell
8-day EMA:	1.87	Sell
20-day EMA:	1.94	Sell
50-day EMA:	2.05	Sell
200-day EMA:	2.3	Sell

Innate Pharma SA Earnings Growth & IPHA Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.

Cellectis SA Earnings Growth & CLLS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and a decrease next year of $0.35 per share.

Innate Pharma SA Technical Analysis

	Oct 16	Oct 18	Oct 21	Oct 22	Oct 23	Oct 24	Oct 25	Oct 28	Oct 29	Oct 30
	Oct
	16	18	21	22	23	24	25	28	29	30
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cellectis SA Technical Analysis

	Oct 16	Oct 18	Oct 21	Oct 22	Oct 23	Oct 24	Oct 25	Oct 28	Oct 29	Oct 30
	Oct
	16	18	21	22	23	24	25	28	29	30
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):